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Abstract. The purpose of this study was to evaluate the effect of resveratrol on cytogenetic damages
of iododeoxyuridine (IUdR) and x-ray megavoltage radiation (6 MV) in spheroid model of U87MG 
glioblastoma cancer cell line using clonogenic and alkaline comet assay. Cells were cultured as sphe-
roids (350 µm) that were treated with 20 μM resveratrol, 1 μM IUdR and 2 Gy of 6 MV x-ray. After
treatment, viability of the cells, colony forming ability and the induced DNA damages were examined 
using trypan blue dye exclusion, colonogenic and alkaline comet assay, respectively. Our results 
showed that resveratrol could significantly reduce the colony number and induce the DNA damages
of the cells treated with IUdR in combination with 6 MV x-ray radiation. That results indicated that
resveratrol as an inhibitor of hypoxia inducible factor 1 alpha (HIF-1α) protein in combination with 
IUdR as a radiosensitizer enhanced the radiosensitization of glioblastoma spheroid cells. 
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Introduction
Malignant gliomas are the most common and deadly in-
tracranial tumors in human being. This tumor includes
50% of total malignant tumors of central nervous system 
(Van Meir et al. 2010). The life expectancy of patients with
glioblastoma (GBM), using the current standards of care 
including surgery, radiotherapy and chemotherapy is on 
average 14 months. For years radiotherapy has been one 
of the important candidates to the treatment of these 
tumors. Although the ionizing radiation hasn’t changed, 
but the ability to focus the beam and fit it to tumors and
reducing the dose received by nearby critical structures 
have been noticeably improved (Van Meir et al. 2010). One 
of the approaches to improve the radiation treatment effi-
ciency is using radiosensitizers. Iododeoxyuridine (IUdR) 
is a halogenated thymidine analogue which incorporates 
into DNA in synthetic phase and sensitizes the tumor cells 
against ionizing radiation (Speth et al. 1989). Although the 
exact mechanism of IUdR hasn’t been understood, but it is 
hypothesized that IUdR induces formation of single strand 
break (SSB) and double strand break (DSB) and leads cells 
to death. Furthermore, the extent of radiosensitization cor-
relates with the level of IUdR-DNA incorporation (Kinsella 
et al. 2007). 
Multicellular spheroid has been proposed as a model 
of early tumor growth from which a better understanding 
of tumor cell heterogeneity and its effects on treatment re-
sponse might be gained. They are a pattern of solid tumors
(in vivo) in a 3-dimentional structure in vitro. So it can esti-
mate the growth and micro environmental condition of real 
tumors. The absorption of IUdR decreases as spheroid grows
in size (Yuhas and Li 1978). On the other hand, by increasing 
the size of spheroid and creating the hypoxic cells, expression 
of hypoxia inducible factor 1 alpha (HIF-1α) is stimulated 
(Menrad et al. 2010). 
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One of the major causes of cell cycle arrest and leading 
cells to G0 phase in hypoxic condition is activation of HIF1α 
protein (Iida et al. 2002). In normoxic condition, HIF1α is 
marked by prolin_hydroxylase_2 and degraded by protea-
some. However, in hypoxic condition, as hydroxylase, von 
Hippel-Lindau (VHL) proteins and HIF are all depressed 
by a lack oxygen, HIF1α is stable and active (Ke and Costa 
2006). HIF1α is a main regulator of oxygen homeostasis 
within cells (Yoon et al. 2013). Under hypoxic condition, 
HIF1 binds the regulatory region of VEGF and induces its 
expression. As a result of it, endothelial cells migrate towards 
hypoxic area and form new blood vessels (Kaur et al. 2005). 
It has been reported that over expression of HIF1 induces 
apoptosis in alveolar epithelial cells by stabilizing p53 pro-
teins and causing cell death (Krick et al. 2005). Resveratrol, 
a polyphenolic compound and naturally occurring phyto-
chemical agent, has been shown to induce growth inhibi-
tion, S-phase arrest and apoptosis in several human cancer 
cell lines (Joe et al. 2002). Furthermore, resveratrol inhibits 
HIF1α and VEGF expressions (Kim et al. 2013, 2014). Res-
veratrol didn’t change HIF1α mRNA level in the cells, sug-
gesting that resveratrol influences HIF1α protein synthesis
or degradation (Wu et al. 2008). Also it has been proved that 
resveratrol inhibits cell proliferation and induction of G0/G1 
growth arrest by the suppression of cyclin D1 expression 
(Benitez et al. 2007). Interestingly no side effect has been seen
so far (Aluyen et al. 2012). Therefore, in the present study, we
have investigated the combined effect of resveratrol and x-ray
megavoltage radiation on the cytogenetic damages caused 
by IUdR in the spheroid model of the U87MG glioblastoma 
cell line. U87MG is an established cell line that can self-as-
semble into large, stable spheroids through a combination 
of intracellular communication and diffusion. In this study,
we used spheroids with 350 μm diameters. This guarantees
the existence of hypoxic cells.
Materials and Methods
Cell line
Human glioblastoma cell line, U87MG, was purchased from 
the Pasteur Institute of Iran. This cell line was maintained
in MEM (PAA laboratories, GmbH, Austria) supplemented 
with 10% fetal bovine serum (FBS) (PAA), 100 U/ml of pen-
icillin and 100 mg/ml of streptomycin (PAA).
Monolayer culture and doubling time calculation
Cells were cultured as monolayer at a density of 104 cells/cm2 
in T-25 tissue culture flasks (Orange Scientific, Belgium). Cul-
tures were maintained at 37°C in a humidified atmosphere and
5% CO2. Cells were harvested by trypsinizing cultures with 
0.25% trypsin and 0.03% ethylene diamine tetraacetic acid 
(EDTA) (Sigma) in phosphate buffer saline (PBS) (Sigma).
Three passages after cells thawing, the cells were cul-
tured at a density of 2 × 104 per well in multiwell plates (24 
wells/plate) (Orange). At 24 hours intervals, the cells from 
triplicate wells were removed by 1 mM EDTA/0.25% Trypsin 
(w/v) treatment and counted in a hemocytometer. An aver-
age of nine counts was used to define each point. Doubling
time was calculated using the slope of the logarithmic phase 
of growth curve. 
Spheroid culture and volume doubling time calculation
Spheroids were initiated using the liquid overlay technique. 
5 × 105 cells were seeded into 100 mm petridishes (Orange) 
coated with a thin layer of 1% agar (Merck) containing 10 
ml of MEM supplemented with 10% FBS. The plates were
incubated at 37°C in a humidified atmosphere and 5% CO2. 
Half of the culture medium was replaced with fresh culture 
medium twice per week (Khoei et al. 2004). At 3 days inter-
vals, two vertical diameters of 20 random spheroids were 
measured using inverted microscope. Spheroid volumes 
were calculated by Eq. 1:
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where “a” and “b” are the small and large diameters of each 
spheroid, respectively. Volume doubling time was calculated 
using the slope of the logarithmic phase of spheroid growth 
curve. 
MTT assay
After 19 days, spheroids with 350 µm of diameter were dis-
persed and plated into 96 well plates (Orange) and incubated 
for 24 h at 37°C in 5% CO2. Cells were subsequently exposed 
to incremental concentration of resveratrol (50–500 μM) 
in 200 μl MEM and incubated for 72 h. Resveratrol was 
dissolved in ethanol and the final concentration of ethanol
added to the medium was 0.1% (v/v). The same concentra-
tion of ethanol was added to the control cultures of cells. 
Then, 20 μl 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetra-
zolium bromide (MTT) (0.5 mg/ml) was added to each 
well protected from light and incubated at 37°C for 3.5 h. 
Formosan crystals were dissolved by adding 200 μl of DMSO 
for 15 min. An ELISA plate reader was used to read the ab-
sorbance with a wave length of 570 nm and 630 nm which 
served as a reference (Nezamtaheri et al. 2012). 
Irradiation procedure
The irradiation of DU145 was performed using x-ray beams
at the Shohadaye Tajrish Hospital. For all cells, irradiation 
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treatments were done under a calibrated 6 MV x-ray beam 
from a Varian linear accelerator (Varian Associates Inc., 
California, USA) with 2 Gy radiation dose. The U87MG
spheroids in T-25 flask were irradiated at room temperature.
The flasks were completely filled with medium. For the x-
ray setup, the irradiation was performed at 100 cm source 
to surface distance (SSD) using a 40 cm × 40 cm field size
(dose rate 1 centiGray/Monitor Unit (cGy/MU)) and under 
a full scatter condition. The Linear Energy Transfer (LET)
of 6 MV x-ray radiation with 28.13 mm practical range at 
target was 213.29 ev/µm. 
Spheroid treatment
Cells were cultured for multicellular spheroid formation. 
On day 21, spheroids with diameter 350 μm were treated 
with IUdR and/or resveratrol and/or 2 Gy of 6 MV x-ray 
radiation. IUdR and/or resveratrol treatment were done for 
1 volume doubling time (67 hours) at 37°C in a humidified
atmosphere and 5% CO2. As control, one group was treated 
with 0.1% ethanol. Other treatments were performed accord-
ing to following group:
1. Treated with resveratrol (IC10:20 μM) for 67 hours 
2. Treated with IUdR (1 μM) for 67 hours
3. Irradiated with x-ray (2 Gy)
4. Treated simultaneously with resveratrol (20 μM) and 
IUdR (1 μM) for 67 hours
5. Treated with resveratrol (20 μM) for 67 hours then irradi-
ated with x-ray (2 Gy)
6. Treated with IUdR (1 μM) for 67 hours then irradiated 
with x-ray (2 Gy)
7. Treated simultaneously with resveratrol (20 μM) and 
IUdR (1 μM) for 67 hours then irradiated with x-ray 
(2 Gy).
The viability of control and treated spheroids were de-
termined using trypan blue dye exclusion assay. Then the
cytotoxic effects and DNA damages were measured using
colonogenic and alkaline comet assay, respectively.
Trypan blue exclusion assay
A suspension of treated and control single cells from sphe-
roid cultures were mixed with trypan blue at a ratio of 9:1. 
After a few minutes the mixture was examined under an
inverted microscope (Motic. A251) and the blue cells were 
considered dead. The percentage of unstained cells out of the
total number of cells was the viability of each cell category.
Colonogenic assay
Irradiated and control single cell suspensions from spheroid 
culture were seeded in 60 mm petridishes (Orange) and 
grown in MEM containing 10% FBS. The cells were incu-
bated at 37°C in a humidified atmosphere of 5% CO2 for 
ten days. After this interval, the colonies which contained
a minimum of 50 cells were counted by an inverted phase 
microscope and the plating efficiency was determined by
Eq. 2.
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Alkaline comet assay
DNA fragmentation was assessed using single cell gel electro-
phoresis (Comet) assay, previously optimized by our group 
(Fazeli et al. 2007). Comet tail moment was determined by 
measuring the fluorescence intensity using the Comet score
software.
Statistical analysis
Data were given as mean ± SEM with n denoting the number 
of experiment. Analysis was performed using one-way analy-
sis of variance (ANOVA) followed by Tukey’s test as the post 
hoc analysis using SPSS version16. The value of p < 0.05 was 
considered to be significant.
Results
Cell characteristics
The U87MG glioblastoma cell line grows as a monolayer
on tissue culture flasks. The growth curve of these cells in
the monolayer culture is shown in Figure 1. The population
Figure 1. Growth curve of U87MG cell line in the monolayer cul-
ture. An average of nine counts was used to define each point. The
values are the mean ± SEM of three experiments.
46 Firouzi et al.
doubling time calculated from this curve was approximately 
18.24 ± 0.84 hours.
Spheroid culture
Spheroids were cultured using the liquid overlay technique. 
The volume doubling time (the period of time required for
a spheroid to double in volume) calculated from the sphe-
roid growth curve was approximately 67 ± 0.91 hours (Ne-
shasteh-Riz et al. 2008). Figure 2 shows the phase contrast 
micrographs of this spheroid 21 days after spheroid culture
of diameter 350 µm.
Viability assay
Immediately after cell treatment with resveratrol (Res), IUdR
and radiation, cells were counted and viability was deter-
mined using the trypan blue dye exclusion assay. Figure 3 
shows the effect of resveratrol, IUdR, radiation and combina-
tion of them on the viability of U87MG spheroids. As can be 
seen, neither of them has any effect on the viability of cells
in spheroid culture (p > 0.05).
MTT assay
The effect of resveratrol on the viability of U87MG cells was
determined by MTT assay is shown in Figure 4. The half
maximal inhibitory concentration (IC50) for resveratrol 
was calculated as 60 μM; IC10 (20 μM) was used for treat-
ment of cells.
Effects of resveratrol, IUdR and x-ray radiation on colony
forming ability
The cell response to drugs and radiation in terms of colony
formation was studied by applying 20 µM resveratrol, 
1 µM IUdR and 2 Gy of 6 MV x-ray radiation on the basis 
of 7 groups described in the section of Materials and Meth-
ods. Plots of plating efficiency versus different treatments
for 21 days old spheroid cultures are shown in Figure 5. In 
350 μM spheroids, 20 µM of resveratrol didn’t reduce the plat-
ing efficiency in comparison with control (p > 0.05). In con-
trast, 1 µM IUdR and 2 Gy x-ray radiation separately reduced 
the colony forming ability of the cells (p < 0.001). The plating
efficiency (PE) of treated spheroids with resveratrol+IUdR
was reduced in comparison with spheroids treated with IUdR 
or resveratrol alone (p < 0.001). Furthermore, colony forma-
Figure 2. Phase contrast micrograph of U87MG cell spheroid with 
350 μm diameter on day 21 after culture initiation. Magnification
×10.
Figure 3. Effects of resveratrol (Res), IUdR and 6 MV
x-ray radiation on viability of U87MG cells in spheroid 
culture. Immediately after treatments, viability of the cells
was assayed using trypan blue dye exclusion assay. The
values are the mean ± SEM of three experiments.
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tion ability was reduced significantly in groups treated with
IUdR+x-ray in comparison with x-ray radiated spheroids 
(p < 0.001), but there is not significantly difference between
the PE of spheroids treated with resveratrol+x-ray compared 
with irradiated spheroids (p = 0.957). Finally, the colony 
forming ability of spheroids treated with resveratrol+IUdR 
and then irradiated with 2 Gy of 6 MV x-ray radiation was 
significantly reduced in compared with spheroids treated
with IUdR+x-ray or resveratrol+x-ray (p < 0.001).
Effects of resveratrol, IUdR and x-ray radiation on DNA
damages
The average of tail moments in each category of cells was
used as an indication of DNA damages. Figure 6 shows 
the distribution of tail moments in control and treated 
spheroids. As it can be seen, the calculated tail moments 
in spheroids treated with resveratrol are as much as control 
group (p = 0.696). But treating spheroids with IUdR or x-
ray and combination of them significantly increased DNA
damage compared with control group (p = 0.002 and p < 
0.001, respectively). Surprisingly, treating spheroids with 
resveratrol+x-ray increased DNA damages compared with 
spheroids exposed to x-ray beam (p < 0.001). However 
the extent of DNA damages induction due to IUdR+x-ray 
was significantly more than resveratrol+x-ray (p < 0.001). 
Finally, the DNA damages were significantly increased
in the presence of resveratrol+IUdR+x-ray as compared 
to the both groups of resveratrol+x-ray and IUdR+x-ray 
(p < 0.001).
Figure 4. Cell viability measured with MTT in U87MG 
spheroid culture. The values of optical density measured at
λ = 570 nm are reported as percentage with respect to the 
optical density registered for untreated control. The latter
considered as 100% of cell viability. The values are the mean
± SEM of three experiments performed in triplicate.
Figure 5. Plating efficiency of U87MG spheroids treated
with resveratrol and IUdR alone or in combination with 6 
MV x-ray beam. The values are the mean ± SEM of three
experiments. * p > 0.05 vs. control, § p < 0.001 vs. control, 
† p < 0.001 vs. IUdR+resveratrol, ≠ p = 0.957, ◊ p < 0.001, 
¥ p < 0.001 vs. IUdR+resveratrol+x-ray.
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Discussion
Hypoxic cells are one the main characteristics of advanced 
tumors which is caused by the structural and functional 
abnormalities of the tumor microvasculature, rapid expan-
sion of tumor mass and tumor associated anemia (Vaupel 
et al. 2001). The first response to hypoxic condition is up
regulating of HIF-1 protein (Dachs et al. 1997; Fruehauf and 
Meyskens 2007). It will decrease apoptosis, increase tumor 
growth, induce VEGF and reduce S-phase indices (Lee et 
al. 2009). It was revealed that disrupting the progression 
of G1/S phase during hypoxia is due to inactivation of CDKs 
(Sangfelt et al. 1999). Resveratrol is a natural polyphenolic 
phytoalexin found in grapes, peanuts and various other 
fruits (Athar et al. 2007). Recent studies show that resveratrol 
induces apoptosis (Jiang et al. 2005), suppresses the angio-
genesis and tumor growth (Tseng et al. 2004) and decreases 
HIF-1 levels in different tumor cell line (Cao et al. 2004; Wu
et al. 2008; Trapp et al. 2010). Zhang et al. (2005) showed that 
resveratrol inhibits HIF-1α protein expression via regulating 
both protein translation and HIF-1α protein degradation. 
Iododeoxyuridine is a halogenated pyrimidine that can be 
incorporated into DNA instead of thymidine during DNA 
replication. This halogenated pyrimidine is considered as
clinical radiosensitizer, where the extent of radiosensitization 
correlates directly with the level of halogenated pyrimidine-
DNA incorporation (Kinsella et al. 1987; Lawrence et al. 
1990; Miller et al. 1992). 
Multicellular tumor spheroids are a well-established 3-D 
in vitro model system that reflects the pathophysiological in 
vivo situation in tumor system. Spheroids show more resist-
ance to ionizing radiation as compared to monolayer cultures 
(Olive and Durand 1985; Bates et al. 2000). Furthermore it 
has been revealed that as spheroids grow, IUdR absorption 
is decreased. Both of mentioned results have been attributed 
to presence of hypoxic and G0 cells in spheroids.
It was reported that treatment of cells with IUdR alone or 
in combination with radiation could increase DNA damage 
in glioblastoma cell line (Phillips 1995) and by enhancing 
the IUdR incorporation into DNA, damages will increase. 
In this study we evaluated that resveratrol can increase the 
radiosensitization of 350 μm glioma spheroids treated with 
IUdR.
As shown in Figure 2, 20 µM resveratrol, 1 µM IUdR and 
2 Gy of x-ray radiation had no significant effects on viability
of the cells. Consistent with previous studies (Khoei et al. 
2011), our data showed that treatment of U87MG glioblas-
toma spheroids with IUdR or radiation and a combination 
of them can increase DNA damages and reduce colony 
forming ability. Figure 5 and 6 indicated that 20 μM res-
veratrol had no effect on colony formation ability and DNA
damages. Also, combination treatment with resveratrol and 
2 Gy of x-ray radiation increased the DNA damages, but 
didn’t change the colony formation ability compared with 
irradiated group alone. This difference between comet and
clonogenic assays results could be due to the time. Alkaline 
comet assay shows single strand breaks (SSB), double strand 
breaks (DSB) and apurinic/apyrimidinic (AP) site. In this 
study, DNA damages were measured immediately after treat-
ment. Therefore, all damages could be detected using comet
assay whereas colony formation ability was assayed after ten
days. Therefore, cells had enough time to repair DNA and
cell damages. Hercbergs et al. (2011) shown that more than 
95% of DSB were repaired within 300 minutes after the x-ray
radiation in U87MG cell line.
Numerous studies have shown that resveratrol can ac-
tivate apoptotic cascade in high dose. It is able to initiate 
apoptosis by different pathway such as the mitochondrial
Figure 6. Calculated tail moments after treatment with
resveratrol, IUdR, x-ray radiation and combination 
of them. The values are the mean ± SEM of three experi-
ments. * p = 0.696 vs. control, § p < 0.005 vs. control, ≠ 
p < 0.001, † p < 0.001 vs. IUdR+resveratrol+x-ray. 
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pathway (Jiang et al. 2005). More ever it is shown that res-
veratrol could arrest cell cycle in G2/M phase which is 
a sensitive phase against radiation (Joe et al. 2002).
Effect of resveratrol on U87MG spheroids should be
investigated. But we speculate that resveratrol can increase 
the cell cycle arrest in G2/M phase and also the number 
of apoptotic cells. But the difference between comet and
clonogenic assays results could be due to the time. Cells 
had enough time to repair DNA damages and therefore cel-
lular damages in colonogenic assay. In addition, the results 
showed that resveratrol could increase DNA and cell dam-
ages induced by radiation in spheroids treated with IUdR 
radiosensitizer. These results are very similar to our previous
study on the role of 2-methoxyestradiol on the cytotoxic 
effects and DNA damages of iododeoxyuridine and 60Co 
radiation in spheroid culture of U87MG glioblastoma cell 
line (Khoei et al. 2011). This might be due to HIF-1α protein
inhibition effect of resveratrol. By suppressing the activity
and expression of HIF-1α, resveratrol caused an increase 
in cell progression into S phase and IUdR absorption and 
finally radiosensitization.
Conclusion
Combined treatment with resveratrol and X-ray significantly
increased DNA and cell damages caused by IUdR. Our find-
ings support the pretreatment of cells with resveratrol+IUdR 
before radiation with 6 MV x-ray to enhance tumor radio-
sensitization and possibly improve the therapeutic index 
for radiation. 
Acknowledgment. This work was supported by grants No. 18033
from the Razi Drug Research Centre of Iran University of Medical 
Sciences. 
References
Aluyen J. K., Ton Q. N., Tran T., Yang A. E., Gottlieb H. B., Bel-
langer R. A. (2012): Resveratrol: potential as anticancer agent. 
J. Diet. Suppl. 9, 45–56
 http://dx.doi.org/10.3109/19390211.2011.650842
Athar M., Back J. H., Tang X., Kim K. H., Kopelovich L., Bickers 
D. R., Kim A. L. (2007): Resveratrol: a review of pre-clinical 
studies for human cancer prevention. Toxicol. Appl. Pharmacol. 
224, 274–283
 http://dx.doi.org/10.1016/j.taap.2006.12.025
Bates R. C., Edward N. S., Yates J. D. (2000): Spheroids and cell 
survival. Crit. Rev. Oncol. Hematol. 36, 61–74
 http://dx.doi.org/10.1016/S1040-8428(00)00077-9
Benitez D. A., Pozo-Guisado E., Alvarez-Barrientos A. , Fernandez-
Salguero P. M., Castellon E. A. (2007): Mechanisms involved in 
resveratrol-induced apoptosis and cell cycle arrest in prostate 
cancer-derived cell lines. J. Androl. 28, 282–293
 http://dx.doi.org/10.2164/jandrol.106.000968
Cao Z., Fang J., Xia C., Shi X., Jiang B. H. (2004): Trans-3,4,5‘-Tri-
hydroxystibene inhibits hypoxia-inducible factor 1alpha and 
vascular endothelial growth factor expression in human ovarian 
cancer cells. Clin. Cancer Res. 10, 5253–5263
 http://dx.doi.org/10.1158/1078-0432.CCR-03-0588
Dachs G. U., Patterson A. V., Firth J. D., Ratcliffe P. J, Townsend K.
M., Startford I. J., Harris A. L. (1997): Targeting gene expression 
to hypoxic tumor cells. Nat. Med. 3, 515–520
 http://dx.doi.org/10.1038/nm0597-515
Fazeli G. R., Khoei S., Nikoofar A. R., Goliaei B. (2007): Reduced 
DNA damage in tumor spheroids compared to monolayer 
cultures exposed to ionizing radiation. Iran. J. Radiat. Res. 5, 
63–69
Fruehauf J. P., Meyskens F. L. (2007): Reactive oxygen species: 
a breath of life or death? Clin. Cancer Res. 13, 789–794
 http://dx.doi.org/10.1158/1078-0432.CCR-06-2082
Hercbergs A. H., Lin H. Y., Davis F. B., Davis P. J., Leith J. T. (2011): 
Radiosensitization and production of DNA double-strand 
breaks in U87MG brain tumor cells induced by tetraiodothy-
roacetic acid (tetrac). Cell Cycle 10, 352–357
 http://dx.doi.org/10.4161/cc.10.2.14641
Iida T., Mine S., Fujimoto H., Suzuki K., Minami Y., Tanaka Y. 
(2002): Hypoxia-inducible factor-1alpha induces cell cycle 
arrest of endothelial cells. Genes Cells 7, 143–149
 http://dx.doi.org/10.1046/j.1356-9597.2001.00512.x
Jiang H., Zhang L., Kuo J., Kuo K., Gautam S.C, Groc L., Rod-
riguez A. I., Koubi D., Hunter T. J., Corcoran G. B., Seidman 
M. D., Levine R. A. (2005): Resveratrol-induced apoptotic 
death in Human U251 Glioma Cells. Mol. Cancer Ther. 4, 
554–561
 http://dx.doi.org/10.1158/1535-7163.MCT-04-0056
Joe A. K., Liu H., Suzui M., Vural M. E., Xiao D., Weinstein I. B. 
(2002): Resveratrol induces growth inhibition, S-phase arrest, 
apoptosis, and changes in biomarker expression in several hu-
man cancer cell lines. Clin. Cancer Res. 8, 893–903
Kaur B., Khwaja F. W., Severson E. A., Matheny S. L., Brat D. J., Van 
Meir E. G. (2005): Hypoxia and the hypoxia-inducible-factor 
pathway in glioma growth and angiogenesis. Neuro. Oncol. 
7, 134–153
 http://dx.doi.org/10.1215/S1152851704001115
Ke Q., Costa M. (2006): Hypoxia-inducible factor-1 (HIF-1). Mol. 
Pharmacol. 70, 1469–1480.
 http://dx.doi.org/10.1124/mol.106.027029
Khoei S., Delfan S., Neshasteh-Riz A., Mahdavi S. R. (2011): 
Evaluation of the combined effect of 2ME2 and (60)Co on the
inducement of DNA damage by IUdR in a spheroid model of 
the u87mg glioblastoma cancer cell line using alkaline comet 
assay. Cell J. 13, 83–90
Khoei S., Goliaei B., Neshasteh-Riz A., Deizadji A. (2004): The role
of heat shock protein 70 in the thermoresistance of prostate 
cancer cell line spheroids. FEBS Lett. 561, 144–148
 http://dx.doi.org/10.1016/S0014-5793(04)00158-9
Kim D. H., Hossain M. A., Kim M. Y., Kim J. A., Yoon J. H., Suh 
H. S., Kim G. Y., Choi Y. H., Chung H. Y., Kim N. D. (2013): 
A novel resveratrol analogue, HS-1793, inhibits hypoxia-in-
duced HIF-1alpha and VEGF expression, and migration in 
human prostate cancer cells. Int. J. Oncol. 43, 1915–1924
50 Firouzi et al.
Kim J. A., Kim D. H., Hossain M. A., Kim M. Y., Sung B., Yoon 
J. H., Suh H., Jeong T. C., Chung H. Y., Kim N. D. (2014): 
HS-1793, a resveratrol analogue, induces cell cycle arrest and 
apoptotic cell death in human breast cancer cells. Int. J. Oncol. 
44, 473–480
 http://dx.doi.org/ 10.3892/ijo.2013.2207
Kinsella T. J., Dobson P. P., Mitchell J. B., Fornace A. J. Jr (1987): 
Enhancement of X ray induced DNA damage by pre-treatment 
with halogenated pyrimidine analogs. Int. J. Radiat. Oncol. Biol. 
Phys. 13, 733–739
 http://dx.doi.org/10.1016/0360-3016(87)90292-6
Kinsella T. J., Kinsella M. T., Seo Y., Berk G. (2007): 5-iodo-2-pyri-
midinone-2‘-deoxyribose-mediated cytotoxicity and radiosen-
sitization in U87 human glioblastoma xenografts. Int. J. Radiat.
Oncol. Biol. Phys. 69, 1254–1261
Krick S., Eul B. G., Hanze J., Savai R., Grimminger F., Seeger W., 
Rose F. (2005): Role of hypoxia-inducible factor-1alpha in 
hypoxia-induced apoptosis of primary alveolar epithelial type 
II cells. Am. J. Respir. Cell. Mol. Biol. 32, 395–403
 http://dx.doi.org/10.1165/rcmb.2004-0314OC
Lawrence T. S., Davis M. A., Maybaum J., Stetson P. L., En-
sminger W. D. (1990): The dependence of halogenated 
pyrimidine incorporation and radiosensitization on the 
duration of drug exposure. Int. J. Radiat. Oncol. Biol. Phys. 
18, 1393–1398
 http://dx.doi.org/10.1016/0360-3016(90)90313-9
Lee S., Rouhi P., Jensen L., Zhang D., Ji H., Hauptmann G., Ingham 
P., Cao Y. (2009): Hypoxia-induced patological angiogenesis 
mediates tumor cell dissemination, invasion and metastasis 
in a zebrafish tumor model. Proc. Natl. Acad. Sci. USA 106, 
19485–19490
 http://dx.doi.org/10.1073/pnas.0909228106
Menrad H., Werno C., Schmid T., Copanaki E., Deller T., Dehne 
N., Brune B. (2010): Roles of hypoxia-inducible factor-1alpha 
(HIF-1alpha) versus HIF-2alpha in the survival of hepatocel-
lular tumor spheroids. Hepatology 51, 2183–2192
 http://dx.doi.org/10.1002/hep.23597
Miller E. M., Fowler J. F., Kinsella T. J. (1992): Linear-quadratic 
analysis of radiosensitization by halogenated pyrimidines: i. 
radiosensitization of human colon cancer cells by iododeoxyu-
ridine. Radiat. Res. 131, 81–89
 http://dx.doi.org/10.2307/3578320
Neshasteh-Riz A., Saki M., Khoei S. (2008): Cytogenetic damages 
from iododeoxyuridine -induced radiosensitivity with and 
without methoxyamine in human glioblastoma spheroids. 
Cell. J. 10, 57–64
Nezamtaheri M. S., Khoei S., Nikoofar A. R., Goliaei B. (2012): 
Comparison of radiosensitizing effect of Resveratrol on mon-
olayer and spheroid culture of DU145 prostatic cell line. Int. J. 
Radiat. Res. 10, 117–181
Olive P. L., Durand R. E. (1985): Effect of intercellular contact on
DNA conformation, radiation-induced DNA damage and mu-
tation in chinese hamster V79 cells. Radiat. Res. 101, 94–101
 http://dx.doi.org/10.2307/3576306
Phillips T. L. (1995): Iododeoxyuridine radiosensitization of human 
glioblastoma cells. Cancer J. Sci. Am. 1, 112–113
Sangfelt O., Erickson S., Castro J., Heiden T., Gustafsson A., Ein-
horn S., Grander D. (1999): Molecular mechanisms underlying 
interferon-alpha-induced G0/G1 arrest: CKI-mediated regula-
tion of G1 Cdk-complexes and activation of pocket proteins. 
Oncogene 18, 2798–2810
 http://dx.doi.org/10.1038/sj.onc.1202609
Speth P. A., Kinsella T. J., Chang A. E., Klecker Jr., Belanger K., 
Smith S., Rowland J., Cupp J. E., Collins J. M. (1989): Iodode-
oxyuridine (IdUrd) incorporation into DNA of human hemat-
opoietic cells, normal liver and hepatic metastases in man: as 
a radiosensitizer and as a marker for cell kinetic studies. Int. J. 
Radiat. Oncol. Biol. Phys. 16, 1247–1250
 http://dx.doi.org/10.1016/0360-3016(89)90292-7
Trapp V., Parmakhtiar B., Papazian V., Willmott L., Fruehauf J. P., 
(2010): Anti-angiogenetic effects of resveratrol mediated by
decreased VEGF and increases TSP1 expression in melanoma-
endothelial cell co-culture. Angiogenesis 13, 305–315
 http://dx.doi.org/10.1007/s10456-010-9187-8
Tseng S. H., Lin S. M., Chen J. C., Su Y. H., Huang H. Y., Chen C. 
K., Lin P. Y., Chen Y., (2004): Resveratrol suppresses the ang-
iogenesis and tumor growth of gliomas in rats. Clin. Cancer 
Res. 10, 2190–2202
 http://dx.doi.org/10.1158/1078-0432.CCR-03-0105
Van Meir E. G., Hadjipanayis C. G., Norden A. D., Shu H. K., Wen 
P. Y., Olson J. J. (2010): Exciting new advances in neuro-oncol-
ogy: the avenue to a cure for malignant glioma. CA. Cancer J. 
Clin. 60, 166–193
 http://dx.doi.org/10.3322/caac.20069
Vaupel P., Thews O., Hoeckel M. (2001): Treatment resistance of
solid tumors: role of hypoxia and anemia. Med. Oncol. 18, 
243–259
Wu H., Liang X., Fang Y., Qin X., Zhang Y., Liu J. (2008): 
Resveratrol inhibits hypoxia-induced metastasis potential 
enhancement by restricting hypoxia-induced factor-1 alpha 
expression in colon carcinoma cells. Biomed. Pharmacother. 
62, 613–621
 http://dx.doi.org/10.1016/j.biopha.2008.06.036
Yoon J, Juhn K. M., Ko J. K., Yoon S. H., Ko Y., Lee C. Y., Lim J. 
H. (2013): Effects of oxygen tension and IGF-I on HIF-1alpha
protein expression in mouse blastocysts. J. Assist. Reprod. 
Genet. 30, 99–105
 http://dx.doi.org/10.1007/s10815-012-9902-z
Yuhas J. M., Li A. P. (1978): Growth fraction as the major deter-
minant of multicellular tumor spheroid growth rates. Cancer 
Res. 38, 1528–1532
 http://cancerres.aacrjournals.org/content/38/6/1528
Zhang Q., Tang X., Lu Q. Y., Zhang Z. F., Brown J., Le A. D. (2005): 
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-
inducible factor-1alpha and VEGF expression in human tongue 
squamous cell carcinoma and hepatoma cells. Mol. Cancer 
Ther. 4, 1465–1474
 http://dx.doi.org/10.1158/1535-7163.MCT-05-0198
Received: February 2, 2014
Final version accepted: July 22, 2014
First published online: November 4, 2014
